Scalp EEG mapping of DBS-induced electric fields

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants who are at least three months post-DBS implantation will have scalp EEG recorded at very high sampling rates (>100 kHz) while their DBS device is operated to capture the tiny, fast electrical potentials induced at the scalp. The recorded signals will be compared with and used to calibrate computer simulations of the DBS electric field. The protocol is observational and does not change clinical DBS settings beyond routine use. The work is led by the University Medical Center Hamburg-Eppendorf in collaboration with the University of Twente.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Provision of written informed consent by the patient
* Age 35 - 85
* patient groups: Parkinson's disease, essential tremor, dystonia
* \>3 months after surgery for DBS

Exclusion Criteria:

none.

Where it's running

• University Medical Center Hamburg-Eppendorf
  Hamburg, Germany Recruiting

Study contacts

• Study coordinator: Bettina C. Schwab, PhD
• Email: b.schwab@uke.de
• Phone: +49 40 7410 26907

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using deep rTMS to improve memory in Alzheimer's Disease

  This study is testing if a new brain treatment called deep rTMS can help improve memory in people with mild to moderate Alzheimer's Disease.

  Recruiting Phase 1/2 University of California, Los Angeles · Los Angeles, California · NCT06597942

• How physical activity might help people with Parkinson’s disease who have DBS-STN implants

  This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.

  Recruiting Medical University of Warsaw · Warsaw · NCT07838636

• GM101 injection to reprogram putamen cells for Parkinson's disease

  This trial will test an experimental gene therapy called GM101, given by brain injection, to see if it is safe for people aged 40–70 with Parkinson's disease lasting five years or more.

  Recruiting Early Phase 1 Genemagic Biosciences Co., Ltd · Changsha · NCT07100171

• Targeted mechanical stimulation used at home to relieve tremors

  This project will try a wearable device that delivers targeted mechanical stimulation at home to reduce moderate-to-severe upper limb tremors in adults with essential tremor or Parkinson's disease.

  Recruiting Encora, Inc. · Cambridge, Massachusetts · NCT07078422

• Using brain stimulation to improve memory and motivation in older adults

  This study is testing if a type of brain stimulation can help improve memory and motivation in older adults, including those showing early signs of Alzheimer's disease.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT06956300

• Understanding how Deep Brain Stimulation affects Freezing of Gait in Parkinson's Disease

  This study is testing how Deep Brain Stimulation can help people with Parkinson's Disease who struggle with Freezing of Gait by looking at their brain and behavior before and after the treatment.

  Recruiting Phase 4 Medical University of South Carolina · Charleston, South Carolina · NCT06951906

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.